Why is Neogen Chemicals falling/rising?

Recent Price Movements and Market Context

Neogen Chemicals has been on a downward trajectory over the past month, with its stock price falling by 18.10%, starkly contrasting with the Sensex's modest gain of 0.95% during the same period. The year-to-date performance further highlights the stock's struggles, registering a steep decline of 43.99%, while the broader market has advanced by over 9%. Over the last year, the stock has lost 34.72%, whereas the Sensex has appreciated by 10.47%. Even over a three-year horizon, Neogen Chemicals has underperformed significantly, delivering a negative return of 9.46% compared to the Sensex's robust 39.39% gain.

On 21-Nov, the stock traded close to its 52-week low, just 3.27% above the lowest price of ₹1,196.5, signalling persistent weakness. The share price has declined for four consecutive days, cumulatively losing 7.05% in that span. Intraday trading saw the stock touch a low of ₹1,237, with heavier volumes concentrated near this lower price point, indicating selling pressure. Additionally, the stock is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—further underscoring bearish sentiment among investors.

Investor participation appears to be waning, as evidenced by a 24.81% drop in delivery volume on 20-Nov compared to the five-day average, suggesting reduced conviction or interest from shareholders. Despite this, liquidity remains adequate for moderate trade sizes, with a 2% threshold of the five-day average traded value supporting transactions up to ₹0.26 crore.

Fundamental Challenges Weighing on the Stock

Neogen Chemicals faces significant fundamental headwinds that have contributed to its share price decline. The company’s ability to service its debt is notably weak, with a high Debt to EBITDA ratio of 4.01 times, indicating substantial leverage and financial risk. This elevated debt burden raises concerns about the firm's capacity to meet interest and principal obligations comfortably.

Profitability metrics also paint a challenging picture. The average Return on Equity (ROE) stands at a modest 9.65%, signalling limited efficiency in generating profits from shareholders’ funds. Operating profit growth has been sluggish, expanding at an annual rate of just 14.16% over the past five years, which is relatively low for a company in the specialty chemicals sector.

Recent quarterly results have been disappointing, with the company reporting a significant 68.5% drop in Profit After Tax (PAT) to ₹3.37 crore compared to the previous four-quarter average. The Return on Capital Employed (ROCE) for the half-year period is at a low 5.72%, and the operating profit to interest coverage ratio has fallen to 1.54 times, indicating tight margins and limited buffer to cover interest expenses.

Valuation metrics further complicate the outlook. Despite trading at a discount relative to peers’ historical valuations, the company’s ROCE of 5.9% suggests an expensive valuation when considering the returns generated on capital employed. Over the past year, profits have declined by 12.7%, reinforcing concerns about the company’s growth prospects and operational efficiency.

Neogen Chemicals’ underperformance is evident not only in the short term but also over longer periods. The stock has lagged behind the BSE500 index over the last three years, one year, and three months, reflecting persistent challenges in delivering shareholder value.

Institutional Holdings and Market Sentiment

One positive aspect is the relatively high institutional holding of 30.38%, which suggests that knowledgeable investors with access to detailed fundamental analysis maintain a stake in the company. However, this has not translated into price support recently, as the stock continues to face selling pressure and negative sentiment.

In summary, Neogen Chemicals’ share price decline on 21-Nov and over recent periods is primarily driven by weak financial performance, high leverage, poor profitability, and sustained underperformance relative to market benchmarks. The combination of disappointing quarterly results, low growth rates, and valuation concerns has dampened investor confidence, resulting in the stock trading near its 52-week lows and below key moving averages.

Investors should carefully weigh these factors against the broader market environment and sector dynamics before considering exposure to Neogen Chemicals, as the current fundamentals suggest ongoing challenges ahead.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →